Grant

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

CountryUnited States
Deadline2027-11-05 (349 days left)
Published2024-12-04
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-297. CFDA: 93.866

The buyer, the value, the full description and the link to the official notice are available with a free account.